-
VBIVQ Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
VBI Vaccines (VBIVQ)
Company Profile
Quarter (USD) | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 32 |
Opened positions | 22 |
Closed positions | 2 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 390.67 mm |
Total shares | 17.30 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Arch Venture Fund Vi | 13.03 mm | $15.96 mm |
Brii Biosciences | 2.13 mm | $3.11 mm |
Perceptive Advisors | 1.38 mm | $850.00 k |
Vanguard | 184.44 k | $111.14 mm |
Geode Capital Management | 143.62 k | $86.57 mm |
BLK BlackRock | 108.59 k | $65.44 mm |
Cambridge Investment Research Advisors | 84.08 k | $51.00 k |
Renaissance Technologies | 57.34 k | $35.00 k |
NTRS Northern Trust | 32.99 k | $19.88 mm |
MS Morgan Stanley | 32.15 k | $19.37 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jul 23 | Steven Gillis | Option (Right to Buy Common Shares) Common Shares | Grant | Acquire A | No | No | 1.3 | 52,500 | 68.25 k | 52,500 |
27 Jul 23 | Blaine H. McKee | Option (Right to Buy Common Shares) Common Shares | Grant | Acquire A | No | No | 1.3 | 35,000 | 45.50 k | 35,000 |
27 Jul 23 | Himes Vaughn B | Option (Right to Buy Common Shares) Common Shares | Grant | Acquire A | No | No | 1.3 | 35,000 | 45.50 k | 35,000 |
27 Jul 23 | Michel DeWilde | Option (Right to Buy Common Shares) Common Shares | Grant | Acquire A | No | No | 1.3 | 35,000 | 45.50 k | 35,000 |
27 Jul 23 | Baxter Jeff | Option (Right to Buy Common Shares) Common Shares | Grant | Acquire A | No | No | 1.3 | 70,000 | 91.00 k | 70,000 |